Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: weatherproof who wrote (38496)	1/7/2017 11:47:32 AM
From: idahoranch1	Read Replies (1) of 63290

venBio has looked at the potential upside of 132. In the CC Behzad said that when looking at the number of indications for 132, and then combinations, the valuation gets "Silly". I agree with that, and maybe that's what has caused Doc to dig in his heels and not agree to a deal in the last 3 years. I think some of us feel the same way (and is why I won't be selling a lot of stock (some, yes) at $10 if things go well with 132. We'll get a better feel in a week and a half with updated data. I doubt that venBio wants a feather in their cap more than they want a possible 50 bagger. That would be a Chief's Headdress. Just what would SILLY be? ??????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next